Hybrid imaging (HI) during cardiovascular interventions enables the peri-procedural visualization of the organs and tissues by means of integrating different imaging modalities. HI can improve the procedural efficacy and safety. This review provides an overview of different systems, their possibilities and the current clinical use and benefits focused on structural and congenital heart diseases. We have performed a literature search and linked the software options to the clinical use in cardiology to gain insight into the clinical use of the systems. In this review, we focus on radiation and contrast exposure, complication rate and procedure time. We found that currently available studies are limited by small cohorts. Nevertheless, HI systems for valvular procedures result in a significant decrease of radiation and contrast exposure. The largest benefit hereof is observed when HI is used in combination with rotational angiography. Furthermore, automatically determined optimal implant angle for transcatheter aortic valve implantation decreases the complication rate significantly. Congenital heart disease interventions that require 2D/3D Transoesophageal echocardiography (TEE) such as septal defects show a significant decrease in radiation and contrast exposure and procedural time when using TEE-Mono-and bi-plane cine angiography and fluoroscopy (XRF) fusion software. MitraClip procedures using these HI systems, however, show only a trend in decrease of these effects. In conclusion, major interventional X-ray vendors offer HI software solutions which are safe and can aid the planning and image guidance of cardiovascular interventions. Even though current HI technologies have limitations, HI provides support in the increasingly complex cardiac interventional procedures to provide better patient care.
Background Noninvasive electrocardiographic imaging (ECGi) using the equivalent double layer (EDL) source model enables both epicardial and endocardial reconstruction of electroanatomical activation patterns during sinus rhythm. The EDL source model has been validated in torso-tank models and animal experiments, however validation in humans using invasive electroanatomical mapping is limited. Purpose Validation of EDL based ECGi using invasive electroanatomical mapping. Methods Ten patients referred for epicardial and endocardial electroanatomical mapping underwent 67 electrode body surface potential mapping (BSPM), cardiac CT imaging and 3D imaging of electrode positions. Anatomical models of the ventricles, lungs and thorax were created and supplemented with electrode positions. Invasive epicardial (4020±1514 contact points), right ventricle endocardial (724±113 contact points) and left ventricle endocardial (459±117 contact points) local activation timing (LAT) maps were compared to ECGi derived LAT maps. Results Included patients (mean age 48±21 years, 80% males) were diagnosed with either arrhythmogenic cardiomyopathy (N=4), dilated cardiomyopathy (N=1), symptomatic premature ventricular complexes (N=3) or myocarditis (N=2). Measured BSMP highly correlated with simulated BSPM (97±2%) with a relative difference of 24% ± 6%. Source models consisted of a mean of 2614±214 nodes with a mean distance between nodes of 8.3±1 mm. Overall, invasive LAT maps and ECGi derived LAT maps showed reasonable correlation for epicardial maps (49% ± 18%) and endocardial maps of the right ventricle (48% ± 27%). Endocardial left ventricular LAT maps showed less correlation (23% ± 28). The absolute difference between invasive and ECGi LAT maps was 16.7±14.2 ms for epicardial maps, 17.2±12.9 ms for right ventricle endocardial maps and 34.0±19.8 ms for left ventricle endocardial maps. Visual comparison showed corresponding areas of breakthrough and regions of latest activation in all cases (Figure). Quantitative comparison of these areas showed a mean absolute difference of 33±7mm or 19±10 ms for epicardial maps, 25±10 mm or 17±13 ms for right ventricle endocardial maps and 39±16 mm or 20±6 ms for left ventricular endocardial maps. Conclusion Overall agreement was observed between EDL based ECGi LAT maps and electroanatomical LAT maps. Future research will focus on further quantification of this agreement and improvement of ECGi mapping accuracy. Funding Acknowledgement Type of funding source: Foundation. Main funding source(s): Netherlands Cardiovascular Research Initiative, an initiative with support of the Dutch Heart Foundation and UCL Hospitals NIHR Biomedical Research Centre.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.